Oncology & Cancer

Novel theranostic agent targets multiple cancer types

A newly discovered radionuclide-based agent (CB-2PA-NT) has been shown to have high tumor uptake, sustained tumor retention, and high contrast in preclinical models, making it a prime candidate for a novel theranostics approach. ...

Vaccination

EU regulator 'convinced' AstraZeneca benefit outweighs risk

The European Union's drug regulator insisted Tuesday that there is "no indication" the AstraZeneca vaccine causes blood clots as governments around the world faced the grimmest of dilemmas: push on with a vaccine known to ...

Vaccination

Testing timeline: What's ahead for COVID-19 vaccines

Pfizer's surprising news that its COVID-19 vaccine might offer more protection than anticipated—an announcement right after a fraught U.S. presidential election campaign—is raising questions about exactly how the different ...

Surgery

Team explores surgery technology resulting in fewer incisions

Through the use of a newly developed needle arthroscope, incisionless and single-incision surgical procedures are possible for repairing certain types of knee and shoulder injuries suggests a series of Marshall University ...

Alzheimer's disease & dementia

Researchers uncover novel amyloidosis

A collaboration led by scientists at Tokyo University of Agriculture and Technology (TUAT), Japan, has discovered a novel amyloid protein that induces amyloidosis in rats. This new amyloid protein is known to be the lipopolysaccharide ...

Other

Daring to dream: Nobel winner's nervous night

When US scientist William Kaelin's phone began ringing at 5:00 am, he wasn't sure whether he was dreaming: Winning the Nobel Medicine Prize had long been a goal, but he also thought it was a long shot.

page 1 from 2